欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/6233/001
药品名称Enzalutamide PharOS 160 mg, filmomhulde tabletten
活性成分
    • enzalutamide 160.0 mg
剂型Film-coated tablet
上市许可持有人Pharos Pharmaceutical Oriented Services Ltd. Lesvou Street End, Thesi Loggos Industrial Zone Metamorfossi, 144 52 Greece
参考成员国 - 产品名称Netherlands (NL)
Enzalutamide PharOS 160 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
      Enzalutamide PharOS
    • Hungary (HU)
    • Romania (RO)
    • Slovak Republic (SK)
    • Slovenia (SI)
    • Malta (MT)
      Enzalutamide PharOS Tablet, film coated 160mg
    • Germany (DE)
      Enzalutamide PharOS 160 mg Filmtabletten
    • Belgium (BE)
      Enzalutamide EG 160 mg filmomhulde tabletten
    • Luxembourg (LU)
许可日期2025/09/24
最近更新日期2025/10/20
药物ATC编码
    • L02BB04 enzalutamide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase